Zildox 50

Zildox 50

oxaliplatin

Manufacturer:

Naprod

Distributor:

Multicare

Marketer:

Multicare
Concise Prescribing Info
Contents
Oxaliplatin
Indications/Uses
Metastatic colorectal cancer in combination w/ 5-fluorouracil & folinic acid.
Dosage/Direction for Use
85 mg/m2 IV infusion over 2-6 hr. Dose may be repeated at intervals of 2 wk. Adjuvant treatment: 65 mg/m2 for 12 cycles.
Contraindications
History of known allergy or other platinum compd. Preexisting sensory neuropathies, myelosuppression, severe renal impairment.
Special Precautions
Pulmonary fibrosis; cough & dyspnea. Increased transaminases & alkaline phosphate. Avoid cold drinks, use of ice & cover exposed skin to cold temperatures or objects. Pregnancy.
Adverse Reactions
Peripheral sensory neuropathy, neutropenia, thrombocytopenia, anemia, nausea, increase transaminases & alkaline phosphatase, diarrhea, emesis, fatigue & stomatitis.
Drug Interactions
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01XA03 - oxaliplatin ; Belongs to the class of platinum-containing antineoplastic agents. Used in the treatment of cancer.
Presentation/Packing
Form
Zildox 50 powd for IV infusion (lyo) 50 mg
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in